新生血管性年龄相关性黄斑变性的抗血管生成治疗 - Suppr

Suppr

超能文献

Antiangiogenic therapy in neovascular age-related macular degeneration.

作者信息

Lin Richard C, Rosenfeld Philip J

机构信息

Bascom Palmer Eye Institute, University of Miami School of Medicine, 900 NW 17th Street, Miami, FL 33136, USA.

出版信息

Int Ophthalmol Clin. 2007 Winter;47(1):117-37. doi: 10.1097/IIO.0b013e31802bd873.

DOI:10.1097/IIO.0b013e31802bd873

PMID:17237677

Abstract

摘要

相似文献

Antiangiogenic therapy in neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性的抗血管生成治疗

Int Ophthalmol Clin. 2007 Winter;47(1):117-37. doi: 10.1097/IIO.0b013e31802bd873.

Re: Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.关于：维替泊芬联合治疗方案用于治疗新生血管性年龄相关性黄斑变性

Retina. 2010 Feb;30(2):380; author reply 380-1. doi: 10.1097/IAE.0b013e3181c771d4.

[Antiangiogenic therapy].[抗血管生成疗法]

Arch Soc Esp Oftalmol. 2005 Aug;80(8):435-6. doi: 10.4321/s0365-66912005000800001.

Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.维替泊芬联合治疗方案用于治疗新生血管性年龄相关性黄斑变性

Retina. 2009 Feb;29(2):133-48. doi: 10.1097/IAE.0b013e3181960a28.

Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.维替泊芬光动力疗法联合玻璃体腔内注射贝伐单抗治疗渗出性年龄相关性黄斑变性。

Acta Ophthalmol Scand. 2006 Dec;84(6):831-3. doi: 10.1111/j.1600-0420.2006.00764.x.

Ranibizumab and nonocular hemorrhage.

Ophthalmology. 2009 Aug;116(8):1593. doi: 10.1016/j.ophtha.2009.03.042.

A cost-effectiveness analysis of three treatments for age-related macular degeneration.三种治疗年龄相关性黄斑变性方法的成本效果分析。

Retina. 2010 Feb;30(2):212-21. doi: 10.1097/IAE.0b013e3181babd8e.

Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration.雷珠单抗与光动力疗法治疗新生血管性年龄相关性黄斑变性的成本效益比较。

Clin Ther. 2008 Dec;30(12):2436-51. doi: 10.1016/j.clinthera.2008.12.025.

Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results.雷珠单抗治疗以典型性为主的新生血管性年龄相关性黄斑变性：第一年ANCHOR研究结果的亚组分析

Am J Ophthalmol. 2007 Dec;144(6):850-857. doi: 10.1016/j.ajo.2007.08.012. Epub 2007 Oct 22.

Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.雷珠单抗治疗新生血管性年龄相关性黄斑变性：综述

Clin Ther. 2007 Sep;29(9):1850-61. doi: 10.1016/j.clinthera.2007.09.008.

引用本文的文献

First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.首例丹麦报道的多囊样视网膜营养不良（遗传性黄斑囊样水肿/常染色体显性遗传性玻璃膜疣）。

Mol Genet Genomic Med. 2021 Apr;9(4):e1652. doi: 10.1002/mgg3.1652. Epub 2021 Mar 10.

Prefilled syringes for intravitreal drug delivery.用于玻璃体内药物递送的预填充注射器。

Clin Ophthalmol. 2019 Apr 23;13:701-706. doi: 10.2147/OPTH.S169044. eCollection 2019.

CCR3 and choroidal neovascularization.CCR3 与脉络膜新生血管。

PLoS One. 2011 Feb 15;6(2):e17106. doi: 10.1371/journal.pone.0017106.

A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap.一种视网膜下基质胶大鼠脉络膜新生血管（CNV）模型，以及 VEGF 陷阱抑制 CNV 及其相关炎症和纤维化。

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):6009-17. doi: 10.1167/iovs.09-4956. Epub 2010 Jun 10.

Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases.视网膜色素上皮细胞中血管内皮生长因子（VEGF）的组成性表达和氧化应激诱导表达受不同的丝裂原活化蛋白激酶的调控方式不同。

Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1487-92. doi: 10.1007/s00417-009-1139-x. Epub 2009 Jul 15.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验